泰地罗新注射液体外抑菌试验及对感染副猪嗜血杆菌仔猪的保护作用

李国基,闫超群,麻雨桥,谢顺,顾欣,曹莹,黄士新,黄显会

Antibacterial Activity in Vitro and Protection of Tildipirosin Injection Against Artificially Infected Haemophilus Paracoides in Piglets

GuoJi LI,ChaoQun YAN,YuQiao MA,Shun XIE,Xin GU,Ying CAO,ShiXin HUANG,XianHui HUANG

表1 试验动物分组与处理

Table 1 The groups and treatment of animals

组别 Groups 数量（头） Numbers (Head) 体重 Weights (kg) 剂量 Dosage (mg·kg-1bw) 给药方案 Drug regimen 健康对照组 Healthy control group 10 12.5±0.6 — 不感染,不给药 No infection, No administration 泰地罗新注射液高剂量组 High dose group of Tildipirosin injection 10 12.9±0.9 8.0 感染,肌注注射 Infection,im 泰地罗新注射液中剂量组 Middle dose group of Tildipirosin injection 10 12.9±1.1 4.0 感染,肌注注射 Infection,im 泰地罗新注射液低剂量组 Low dose group of Tildipirosin injection 10 12.7±0.9 2.0 感染,肌注注射 Infection,im 泰拉霉素注射液 Tulathromycin injection 10 13.1±0.5 2.5 感染,肌注注射 Infection,im 感染对照组 Infective control group 10 12.5±0.6 — 感染,不给药 Infection, No administration